Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers

NCT02264158 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2014-10-15

No results posted yet for this study

Summary

Assessment of the influence of telmisartan, lacidipine and their combination on the QTC interval of the ECG

Conditions

  • Healthy

Interventions

DRUG

Telmisartan high

DRUG

Telmisartan low

DRUG

Lacidipine high

DRUG

Lacidipine low

DRUG

Placebo

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2002-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02264158 on ClinicalTrials.gov